Skip to main content

Animations

MJFF Publications

1511 - 1520 of 6568 Results
Title
Year
  • Year
  • 2019
  • 2023
  • 2023
  • 2023
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27614
    Citation Count: 94
  • Summary Details
    OPEN
    Title: American Football Play and Parkinson Disease Among Men
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2023.28644
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2023.2338
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Is REM Sleep Behavior Disorder Changing? Secular Changes Versus Referral Patterns
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mdc3.13842
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 Sequences
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903160.72715.2d
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-021-00509-5
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.78055
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-022-15874-4
    Citation Count: 111
  • Summary Details
    OPEN
    Title: Differential impact of individual autonomic domains on clinical outcomes in Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-022-11221-9
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Integrating Data Directly into Publications with Augmented Reality and Web-Based Technologies – Schol-AR
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-022-01426-y
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.